For citations:
Belov BS, Muravyeva NV, Tarasova GM, Baranova MM. Use of Janus kinase inhibitors in the treatment of immunoinflammatory rheumatic diseases: safety issues. Meditsinskiy sovet = Medical Council. 2021;(2):76-84. (In Russ.) https://doi.org/10.21518/2079-701X-2021-2-76-84